REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Phosphorus Containing Other Than Solely As Part Of An Inorganic Ion In An Addition Salt Doai > Nitrogen Containing Hetero Ring > Hetero Ring Is Five-membered > Two Or More Hetero Atoms In The Five-membered Ring Two Or More Hetero Atoms In The Five-membered RingTwo Or More Hetero Atoms In The Five-membered Ring patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/04/07 - 20070004682 - Di-substituted oxadiazoles as cxc-chemokine receptor ligands and the pharmaceutically acceptable salts thereof. X is N or N+O−, and Y is N or N+O−, provided that at least X or Y is N. The compounds are useful for the treatment of chemokine-mediated diseases such as COPD. ... 08/31/06 - 20060194768 - Thiazole and thiadiazole inhibitors of tyrosine phosphatases Compounds and compositions are provided for modulating the activity of protein tyrosine phosphatases. In one embodiment, the compounds and compositions are thiazoles and thiadiazoles that inhibit the activity of protein tyrosine phosphatase 1B. ... 07/20/06 - 20060160773 - Combretastatin derivatives with cytotoxic action in which the groups are as defined in the description here below. Said compounds, though chemically related to the structure of cis/trans-combretastatin, do not always bind tubulin, but nevertheless exhibit cytotoxic activity of interest in the oncological field as anticancer and/or antiangiogenic agents. ... 07/13/06 - 20060154899 - Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of ... 06/22/06 - 20060135483 - Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases Compounds, pharmaceutical compositions, and methods for treating, preventing, or ameliorating symptoms associated with diseases such as diabetes, cancer, neurodegenerative diseases, and obesity are provided. The compounds and compositions inhibit protein tyrosine phosphatase enzymes, e.g., PTP-1B. ... 03/09/06 - 20060052348 - Oxazolo-naphthyl acids and methods of using them to modulate PAI-1 expression and to treat PAI-1 related disorders. ... ### FreshPatents.com Support |